CLINICAL_TRIALS
trial_result
· 2021-03-03
Clinical Trial Update: Autologous Platelet Lysate in Corneal Epithelial Defects [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating autologous platelet lysate for persistent corneal epithelial defects has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hanan Jafar | Conditions: Persistent Corneal Epithelial Defect | Phase 1, Phase 2 | Status: COMPLETED